A Look At The Fair Value Of Amplifon S.p.A. (BIT:AMP)
In this article we are going to estimate the intrinsic value of Amplifon S.p.A. ( BIT:AMP ) by estimating the company's...
Has the Italian Healthcare Sector valuation changed over the past few years?
|Thu, 20 Jan 2022||€33.2b||€6.8b||€1.0b||23x|
|Sat, 18 Dec 2021||€35.8b||€6.8b||€1.0b||23.3x|
|Mon, 15 Nov 2021||€38.3b||€6.7b||€997.2m||25x|
|Wed, 13 Oct 2021||€34.5b||€6.6b||€1.0b||26.6x|
|Fri, 10 Sep 2021||€38.3b||€6.6b||€1.0b||29.8x|
|Sun, 08 Aug 2021||€35.9b||€6.4b||€1.0b||29.8x|
|Sat, 01 May 2021||€30.6b||€6.1b||€925.0m||23.4x|
|Tue, 02 Feb 2021||€30.8b||€5.8b||€866.3m||24.7x|
|Fri, 06 Nov 2020||€30.4b||€5.7b||€815.4m||33.2x|
|Mon, 10 Aug 2020||€28.7b||€5.5b||€754.5m||32.8x|
|Sun, 03 May 2020||€23.3b||€5.5b||€736.0m||27x|
|Wed, 05 Feb 2020||€21.9b||€5.5b||€738.1m||28.2x|
|Sat, 09 Nov 2019||€20.3b||€5.3b||€703.2m||26x|
|Fri, 02 Aug 2019||€20.9b||€5.1b||€684.2m||25.6x|
|Mon, 06 May 2019||€17.8b||€4.9b||€668.1m||26.4x|
|Thu, 07 Feb 2019||€15.6b||€4.6b||€633.7m||21.1x|
Current Industry PE: Investors are relatively neutral on the industry at the moment, considering it's trading close to its 3-year average PE ratio of 27.0x. It appears they believe that earnings will grow in-line with historical growth rates.
Past Earnings Growth: The earnings for companies in the Healthcare industry have grown 17% per year over the last three years, and revenues for these companies have grown 14% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Which industries have driven the changes within the Italian Healthcare sector?
Industry PE: Investors are most optimistic about the Healthtech industry which is trading above its 3-year average PE ratio of 26.0x. This is likely because analysts are expecting annual earnings growth of 38%, which is higher than its past year's earnings growth of 3.7% per year. Meanwhile, investors are most pessimistic about the Biotech industry, which is trading below its 3-year average of 23.8x.
Forecasted Growth: Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 64% over the next 5 years. Meanwhile, the Biotech industry is expected to see its earnings decline by 34% per year over the next few years.
Recordati Industria Chimica e Farmaceutica
Garofalo Health Care